Pharma, biotech firms keen on European market

RELATED NEWS Evolving therapies to greatly aid in controlling obesity Granules India signs MoU with PharmaMatch Glenmark US arm in pact with Lehigh 58th Indian Pharmaceutical Congress inaugurated in Mumbai Nifty BSE | NSE 29/05/12 Are Mutual Funds betting on Nifty?

As Group Chairman of Merieux Group of France, Alain Merieux, whose vaccine company Alliance Merieux recently acquired 60% from Shantha Biotechnics said, the acquisition will give the French company access to the lucrative Asian markets as well as sound research and development capabilities.

The latest in the Europe calling line has been Bharat Biotech, which concluded a license agreement with the Belgium-based ThromboGenics. The objective of Bharat Biotech in the agreement is to acquire technology to make a cost-effect clot-buster drug, to help heart patients in developing countries.

For Dr Reddy's, the acquisition of Betapharm or for Aurobindo Pharma, which acquired the UK-based Milpharm Ltd, and Matrix Laboratories, which bought the Belgium-based Docpharma for $263 million in June 2005, the acquisition route has been essentially to get a foothold and expand in the growing European markets. These companies already have a strong presence in the US market, which is the biggest, industry experts explained.

Granules India, a focused granulations company, has opted for the joint collaboration mode with the Dutch PharmaMatch to develop, manufacture and market formulations in the European market, starting with Paracetomol.

The lesser known Ocimum Biosolutions has made two acquisitions in the last 18 months in Europe. First, it bought the biotech division of MWG Biotech of Germany to bolster its DNA Chip or Microarray capability and in November, it acquired the Oligo division of the Netherlands-based Isogen Life Sciences, to expand its capabilities in the segment, especially in Europe.

Several other pharma and biotech majors are in the process of expanding into the European markets, even as major global corporates are seriously eyeing the built up capacities and human resources existing in the large number of small bulk and formulations companies in Hyderabad.

Taken from Business Line

thehindubusinessline.in